Combined use of Flex28 cochlear implant array and electric acoustic stimulation processor (DUET2): a case report

  • Matsuda Yusuke
    Audiology and Hearing Implant Center in University of Miyazaki Hospital Department of otorhinolaryngology, Kagoshima City Hospital
  • Okuda Takumi
    Department of otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, University of Miyazaki
  • Kamie Ai
    Audiology and Hearing Implant Center in University of Miyazaki Hospital Department of otorhinolaryngology, Kagoshima City Hospital
  • Takaki Minoru
    Department of otorhinolaryngology, Kagoshima City Hospital
  • Ganaha Akira
    Department of otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, University of Miyazaki
  • Tono Tetsuya
    Department of otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, University of Miyazaki

Bibliographic Information

Other Title
  • 通常人工内耳電極(Flex28<sup>TM</sup>)と電気音響刺激型オーディオプロセッサー(DUET2<sup>TM</sup>)併用による残存聴力活用型人工内耳症例
  • 通常人工内耳電極(Flex28)と電気音響刺激型オーディオプロセッサー(DUET2)併用による残存聴力活用型人工内耳症例
  • ツウジョウ ジンコウ ナイジ デンキョク(Flex28)ト デンキ オンキョウ シゲキガタ オーディオプロセッサー(DUET2)ヘイヨウ ニ ヨル ザンソン チョウリョク カツヨウガタ ジンコウ ナイジ ショウレイ

Search this article

Abstract

<p>In Japan, electric acoustic stimulation (EAS) has been approved only with the use of a short electrode array (e.g., Flex24TM) and specific audio processors with built-in acoustic stimulation components, such as DUET2 TM and SONNET EAS TM manufactured by MED-EL. We herein report a case showing the EAS benefit from the combined use of the DUET2 processor and the Flex28 electrode array, which has not yet been approved for EAS in Japan. A 53-year-old female with bilateral sensorineural hearing loss who underwent EAS surgery using a Flex24 electrode in her left ear, followed by late-onset deterioration of residual hearing in the operated ear 2 years and 4 months after implantation. She underwent a second cochlear implant surgery at the age of 59 years using a Flex28 electrode and an RONDO2 audio processor in her right ear. Because adequate preservation of low-frequency residual hearing was confirmed 6 months after implantation, she started to use her DUET2 audio processor on the right ear for EAS. The Japanese monosyllable scores examined 18 months postoperatively were better with EAS than with electric stimulation alone either under quiet or background noise conditions. This case study suggests the importance of the clinical availability of the EAS processor based on hearing capabilities regardless of the length and shape of the implanted electrode array.</p>

Journal

  • Otology Japan

    Otology Japan 31 (4), 479-484, 2021

    Japan Otological Society

Details 詳細情報について

Report a problem

Back to top